These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Serum uric acid levels in untreated and PUVA-treated patients with psoriasis. Brenner W; Gschnait F Acta Derm Venereol Suppl (Stockh); 1979; 87():41-2. PubMed ID: 294782 [TBL] [Abstract][Full Text] [Related]
5. DNA in psoriatic epidermis. Sondergaard J; Lerche A; Bohr V; Leik V; Wadskov S Acta Derm Venereol Suppl (Stockh); 1979; 87():59-63. PubMed ID: 294785 [TBL] [Abstract][Full Text] [Related]
6. Ultrastructural changes in nuclei and nucleoli in psoriatic epidermis during and after PUVA therapy. Tsuji T; Cox AJ Acta Derm Venereol; 1978; 58(5):383-9. PubMed ID: 82346 [TBL] [Abstract][Full Text] [Related]
7. Response of psoriatic nails to oral photochemotherapy. Marx JL; Scher RK Arch Dermatol; 1980 Sep; 116(9):1023-24. PubMed ID: 7416754 [TBL] [Abstract][Full Text] [Related]
8. Keratin polypeptide profile in psoriatic epidermis normalized by treatment with etretinate (aromatic retinoid Ro 10-9359). Staquet MJ; Faure MR; Reano A; Viac J; Thivolet J Arch Dermatol Res; 1983; 275(2):124-9. PubMed ID: 6191725 [TBL] [Abstract][Full Text] [Related]
11. Skin typing for assessment of skin cancer risk and acute response to UV-B and oral methoxsalen photochemotherapy. Stern RS; Momtaz K Arch Dermatol; 1984 Jul; 120(7):869-73. PubMed ID: 6732259 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of psoriasis with psoralen derivatives and long-wave ultraviolet radiation (PUVA method). II. Durability of therapeutic results and recurrences. Comparison of Oxsoralen and Beroxan]. Nowakowski H; Jakubowicz K Przegl Dermatol; 1979; 66(1):81-6. PubMed ID: 424624 [No Abstract] [Full Text] [Related]
13. [Study of normal and pathological keratinization using anti-keratin polypeptide sera (author's transl)]. Thivolet J; Viac J; Staquet MJ; Schmitt D Ann Dermatol Venereol; 1980 May; 107(5):357-64. PubMed ID: 6164332 [TBL] [Abstract][Full Text] [Related]
14. Psoralens and UV-A and UV-B twice weekly for the treatment of psoriasis. Diette KM; Momtaz-T K; Stern RS; Arndt KA; Parrish JA Arch Dermatol; 1984 Sep; 120(9):1169-73. PubMed ID: 6476854 [TBL] [Abstract][Full Text] [Related]
15. Comparison of phototherapy (UV-B) and photochemotherapy (PUVA) for clearing and maintenance therapy of psoriasis. Boer J; Hermans J; Schothorst AA; Suurmond D Arch Dermatol; 1984 Jan; 120(1):52-7. PubMed ID: 6691715 [TBL] [Abstract][Full Text] [Related]
16. Topical methoxsalen followed immediately by long-wave UV irradiation. A preliminary report on the treatment of psoriasis. Danno K; Toda K; Ishida H; Horio T Arch Dermatol; 1982 Jul; 118(7):471-3. PubMed ID: 7092270 [TBL] [Abstract][Full Text] [Related]
17. [UV-therapy of psoriasis. Half-side comparison between oral photochemotherapy (PUVA) and selective UV-phototherapy (SUP)]. Hönigsmann H; Fritsch P; Jaschke E Z Hautkr; 1977 Nov; 52(21):1078-82. PubMed ID: 930225 [No Abstract] [Full Text] [Related]
18. [General principles of radiation and drug dosage and determination of individual sensitivity of patients to photochemotherapy treatment (PUVA) of psoriasis]. Jakubowicz K; Langner A; Nowakowski H; Wolska H Przegl Dermatol; 1979; 66(4):337-43. PubMed ID: 493560 [No Abstract] [Full Text] [Related]
19. Photochemotherapy of psoriasis with methoxsalen and longwave ultraviolet light (PUVA). Bond CA; Grant K; Boh L Am J Hosp Pharm; 1981 Jul; 38(7):990-5. PubMed ID: 7020414 [TBL] [Abstract][Full Text] [Related]
20. Risks and benefits of the treatment of psoriasis. Epstein JH N Engl J Med; 1979 Apr; 300(15):852-3. PubMed ID: 423922 [No Abstract] [Full Text] [Related] [Next] [New Search]